{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:44:47Z","timestamp":1777866287626,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008758","name":"Council of Science and Technology, U.P.","doi-asserted-by":"publisher","award":["UP-CST\/D-2245"],"award-info":[{"award-number":["UP-CST\/D-2245"]}],"id":[{"id":"10.13039\/501100008758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["VIR\/12\/2022\/ECD-1"],"award-info":[{"award-number":["VIR\/12\/2022\/ECD-1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127501","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:01:01Z","timestamp":1752584461000},"page":"127501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antigens activated SOCS3+CD200R+CD4+ T cells are critical to Leishmania pathogenesis and a distinctive target for vaccine development"],"prefix":"10.1016","volume":"62","author":[{"given":"Abhishek","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baishakhi","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127501_bb0005","series-title":"New Delhi: World Health Organization. [Regional Office for South-East Asia]","article-title":"editor Report of Meeting of the Regional Technical Advisory Group (RTAG) on visceral leishmaniasis and the national visceral leishmaniasis programme managers of endemic member states 2020","year":"2020"},{"key":"10.1016\/j.vaccine.2025.127501_bb0010","doi-asserted-by":"crossref","first-page":"1052478","DOI":"10.3389\/fmicb.2022.1052478","article-title":"Leishmaniasis: recent epidemiological studies in the Middle East","volume":"13","author":"Knight","year":"2022","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127501_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","article-title":"Post kala-azar dermal leishmaniasis: an unresolved mystery","volume":"30","author":"Mukhopadhyay","year":"2014","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0020","series-title":"Leishmania Parasites","article-title":"Epidemiology of visceral leishmaniasis in India","author":"Rajan","year":"2023"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127501_bb0025","doi-asserted-by":"crossref","first-page":"28455","DOI":"10.1038\/s41598-024-78915-0","article-title":"Nationwide cross-sectional surveillance of leishmania donovani in phlebotomine sand flies and its impact on national kala-azar elimination in India","volume":"14","author":"Shah","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127501_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40249-016-0112-2","article-title":"Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective","volume":"5","author":"Singh","year":"2016","journal-title":"Infect Dis Poverty"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2025.127501_bb0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/2049936116646063","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Therapeutic Advances in Infectious Disease"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127501_bb0040","first-page":"812","volume":"13","author":"Ayala","year":"2024","journal-title":"Advances in Leishmania Vaccines: Current Development and Future Prospects"},{"key":"10.1016\/j.vaccine.2025.127501_bb0045","first-page":"151","volume":"13","author":"Reiner","year":"1995","journal-title":"The regulation of immunity to Leishmania major"},{"key":"10.1016\/j.vaccine.2025.127501_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109098","article-title":"Functional aspects of T cell diversity in visceral leishmaniasis","volume":"117","author":"Jawed","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127501_bb0055","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nyl\u00e9n","year":"2007","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127501_bb0060","first-page":"4623","article-title":"IL-12 enhances Th1-type responses in human Leishmania donovani infections","volume":"154","author":"Ghalib","year":"1995","journal-title":"Journal of Immunology (Baltimore, Md\u202f: 1950)"},{"key":"10.1016\/j.vaccine.2025.127501_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.624009","article-title":"Role of cytokines in experimental and human visceral leishmaniasis","volume":"11","author":"Samant","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fimmu.2013.00156","article-title":"Interferon gamma in leishmaniasis","volume":"4","author":"Kima","year":"2013","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127501_bb0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.it.2009.09.009","article-title":"Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function","volume":"30","author":"Palmer","year":"2009","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127501_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2567.2011.03520.x","article-title":"Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins","volume":"135","author":"Knosp","year":"2012","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127501_bb0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","article-title":"SOCS regulation of the JAK\/STAT signalling pathway","volume":"19","author":"Croker","year":"2008","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127501_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.imbio.2007.10.008","article-title":"Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins","volume":"213","author":"Dalpke","year":"2008","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127501_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/intimm\/dxq472","article-title":"Aberrant IL-4 production by SOCS3-over-expressing T cells during infection with leishmania major exacerbates disease manifestations","volume":"23","author":"Nakaya","year":"2011","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127501_bb0100","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1074\/jbc.M113.496323","article-title":"<em>leishmania donovani<\/em> prevents oxidative burst-mediated apoptosis of host macrophages through selective induction of suppressors of cytokine Signaling (SOCS) proteins*","volume":"289","author":"Srivastav","year":"2014","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127501_bb0105","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4049\/jimmunol.1900412","article-title":"Differential induction of SOCS isoforms by leishmania donovani impairs macrophage\u2013T cell cross-talk and host Defense","volume":"204","author":"Chandrakar","year":"2020","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.vaccine.2025.127501_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156461","article-title":"Aberrant expression of SOCS impairs the anti-leishmanial immune response","volume":"174","author":"Jafarzadeh","year":"2024","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127501_bb0115","first-page":"501","volume":"88","author":"Reiner","year":"1984","journal-title":"Arachidonic acid metabolism in murine leishmaniasis (Donovani): ex-vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127501_bb0120","first-page":"556","article-title":"Malemud CJJoi","volume":"134","author":"Reiner","year":"1985","journal-title":"Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127501_bb0125","first-page":"2330","volume":"193","author":"Saha","year":"2014","journal-title":"Prostaglandin E2 negatively regulates the production of inflammatory cytokines\/chemokines and IL-17 in visceral leishmaniasis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127501_bb0130","first-page":"631","volume":"143","author":"Lee","year":"2019","journal-title":"T cell\u2013intrinsic prostaglandin E2-EP2\/EP4 signaling is critical in pathogenic TH17 cell\u2013driven inflammation"},{"key":"10.1016\/j.vaccine.2025.127501_bb0135","series-title":"Centrin-Deleted Leishmania donovani Parasites Help CD4+ T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200\u2013CD200R Immune Inhibitory Axis","first-page":"9","author":"Singh","year":"2018"},{"key":"10.1016\/j.vaccine.2025.127501_bb0140","series-title":"CD300a Receptor Blocking Enhances Early Clearance of Leishmania donovani From Its Mammalian Host Through Modulation of Effector Functions of Phagocytic and Antigen Experienced T Cells","first-page":"12","author":"Singh","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127501_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106826","article-title":"Leishmania donovani induces CD300a expression to dampen effector properties of CD11c(+) dendritic and antigen activated CD8(+) T cells","volume":"239","author":"Anand","year":"2023","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2025.127501_bb0150","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijbiomac.2020.02.189","article-title":"The CD200-CD200R cross-talk helps leishmania donovani to down regulate macrophage and CD4(+)CD44(+) T cells effector functions in an NF\u03baB independent manner","volume":"151","author":"Rawat","year":"2020","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127501_bb0155","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.4049\/jimmunol.180.7.4355","article-title":"Modulation of dendritic cell function by leishmania parasites","volume":"180","author":"Soong","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127501_bb0160","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/iai.62.3.1058-1063.1994","article-title":"Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis","volume":"62","author":"Miralles","year":"1994","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127501_bb0165","first-page":"177","volume":"203","author":"Woelbing","year":"2006","journal-title":"Uptake of Leishmania major by dendritic cells is mediated by Fc\u03b3 receptors and facilitates acquisition of protective immunity"},{"key":"10.1016\/j.vaccine.2025.127501_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molimm.2023.09.014","article-title":"Adjuvantation of whole-killed leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides protection against wild-type parasites","volume":"163","author":"Singh","year":"2023","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156435","article-title":"Leishmania antigens activated CD4(+) T cells expressing CD200R receptors are the prime IL-10 producing phenotype and an important determinant of visceral leishmaniasis pathogenesis","volume":"173","author":"Singh","year":"2024","journal-title":"Cytokine"},{"issue":"26","key":"10.1016\/j.vaccine.2025.127501_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126373","article-title":"A squalene oil emulsified MPL-A and anti-CD200\/CD300a antibodies adjuvanted whole-killed leishmania vaccine provides durable immunity against L. donovani parasites","volume":"42","author":"Mahapatra","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127501_bb0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127501_bb0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective leishmania metacyclic promastigotes by density gradient centrifugation","volume":"99","author":"Sp\u00e4th","year":"2001","journal-title":"Exp Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127501_bb0195","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0200","doi-asserted-by":"crossref","first-page":"1088038","DOI":"10.3389\/fonc.2023.1088038","article-title":"Cancel cancer: the immunotherapeutic potential of CD200\/CD200R blockade","volume":"13","author":"Choe","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4939-9884-5_13","article-title":"Immunohistochemistry (IHC): chromogenic detection of 3-Phosphohistidine proteins in formaldehyde-fixed, frozen mouse liver tissue sections","volume":"2077","author":"Luhtala","year":"2020","journal-title":"Methods in molecular biology (Clifton, NJ)"},{"key":"10.1016\/j.vaccine.2025.127501_bb0210","first-page":"10","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis","author":"Dayakar","year":"2019","journal-title":"Opportunities for Novel Diagnostics and Immunotherapy"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127501_bb0215","article-title":"T-cell and soluble co-inhibitory receptor expression in patients with visceral leishmaniasis are markers of treatment response and clinical outcome. Open forum","volume":"11","author":"Ademe","year":"2024","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127501_bb0220","series-title":"Unraveling the Role of Immune Checkpoints in Leishmaniasis","first-page":"12","author":"de Freitas e Silva","year":"2021"},{"key":"10.1016\/j.vaccine.2025.127501_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.prostaglandins.2017.06.002","article-title":"CD200 selectively upregulates prostaglandin E(2) and D(2) synthesis in LPS-treated bone marrow-derived macrophages","volume":"133","author":"Kern","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127501_bb0230","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.4049\/jimmunol.1400399","article-title":"Prostaglandin E2 negatively regulates the production of inflammatory cytokines\/chemokines and IL-17 in visceral leishmaniasis","volume":"193","author":"Saha","year":"2014","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127501_bb0235","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jaci.2018.05.036","article-title":"T cell-intrinsic prostaglandin E(2)-EP2\/EP4 signaling is critical in pathogenic T(H)17 cell-driven inflammation","volume":"143","author":"Lee","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0240","article-title":"Unraveling the role of immune checkpoints in leishmaniasis","volume":"12","author":"de Freitas","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fimmu.2016.00187","article-title":"Modulation of innate immune mechanisms to enhance leishmania vaccine-induced immunity: role of coinhibitory molecules","volume":"7","author":"Gannavaram","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155839","article-title":"The expression of PD-1 and its ligands increases in leishmania infection and its blockade reduces the parasite burden","volume":"153","author":"Jafarzadeh","year":"2022","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127501_bb0255","first-page":"1433","volume":"34","author":"Zubairi","year":"2004","journal-title":"Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127501_bb0260","first-page":"155","volume":"193","author":"Rastogi","year":"2021","journal-title":"Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127501_bb0265","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.20092017","article-title":"Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection","volume":"207","author":"Kim","year":"2010","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127501_bb0270","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","article-title":"CD4+ T cell memory","volume":"24","author":"K\u00fcnzli","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.127501_bb0275","volume":"15","author":"Tiwari","year":"2024","journal-title":"The development and maintenance of immunity against visceral leishmaniasis"},{"key":"10.1016\/j.vaccine.2025.127501_bb0280","doi-asserted-by":"crossref","first-page":"1304696","DOI":"10.3389\/fimmu.2024.1304696","article-title":"Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis","volume":"15","author":"Nateghi-Rostami","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127501_bb0285","first-page":"925","volume":"13","author":"Butler","year":"2011","journal-title":"Immunologic considerations for generating memory CD8 T cells through vaccination"},{"issue":"35","key":"10.1016\/j.vaccine.2025.127501_bb0290","doi-asserted-by":"crossref","first-page":"17409","DOI":"10.1073\/pnas.1904125116","article-title":"IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3","volume":"116","author":"Wang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127501_bb0295","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e11","article-title":"IL-15 in T-cell responses and immunopathogenesis","volume":"24","author":"Lee","year":"2024","journal-title":"Immune network"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127501_bb0300","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2613.2001.00199.x","article-title":"Tissue granuloma structure-function in experimental visceral leishmaniasis","volume":"82","author":"Murray","year":"2001","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127501_bb0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13071-018-2624-z","article-title":"Histopathological and immunohistochemical characterisation of hepatic granulomas in leishmania donovani-infected BALB\/c mice: a time-course study","volume":"11","author":"Salguero","year":"2018","journal-title":"Parasit Vectors"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127501_bb0310","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00281-015-0548-7","article-title":"Lessons from other diseases: granulomatous inflammation in leishmaniasis","volume":"38","author":"Kaye","year":"2016","journal-title":"Semin Immunopathol"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2025.127546","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:22:49Z","timestamp":1777537369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25007984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":62,"alternative-id":["S0264410X25007984"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127501","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigens activated SOCS3+CD200R+CD4+ T cells are critical to Leishmania pathogenesis and a distinctive target for vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127501"}}